Ketotifen
Also known as: Ketotifen Fumarate, Zaditen, Zaditor, Ketotifen
Lower numbers = closer to natural. Higher numbers = more enhanced.
Why this rating?
Ketotifen is an antihistamine/mast-cell stabiliser with no anabolic or thermogenic action of its own. In the PED world it is used for one purpose: it upregulates beta-2 adrenergic receptors, which lets a clenbuterol (beta-2 agonist) cycle keep working past the point where receptor downregulation would normally kill its fat-loss effect. Not WADA prohibited. Rated 1 (basically natty): ketotifen itself builds no muscle, burns no fat, and alters no hormones; it is purely a receptor-sensitivity tool that keeps another drug working, so on its own it does not move the natural physique/performance ceiling.
Overview
A second-generation H1-antihistamine and mast-cell stabiliser used medically for allergy and asthma. Its relevance to physique athletes is a side property: it restores and upregulates beta-2 adrenergic receptor density. Because clenbuterol and other beta-2 agonists lose effect as those receptors downregulate within a couple of weeks, ketotifen is run to reset the receptors and extend the useful window of a clenbuterol cycle. It is sedating, so it is taken at night.
Important Warnings
- •Strongly sedating: do not drive or operate machinery until you know how it affects you; take at bedtime.
- •It potentiates clenbuterol's effects, including cardiovascular ones (tachycardia, tremor), the real risk lives in the clenbuterol, so keep clen dosing conservative.
- •Can increase appetite, a headwind during a fat-loss phase.
- •Additive sedation with alcohol and other CNS depressants.
Purpose & Use Cases
Extending Clenbuterol Cycles
The core PED use. By upregulating beta-2 receptors, ketotifen offsets the receptor downregulation that normally makes clenbuterol stop working after ~2-3 weeks, letting the fat-loss effect run longer or resetting receptors mid-cycle.
Beta-2 Receptor 'Reset'
Run for the last stretch of a clen cycle (or during a break) to bring shut-down receptors back up, so the next phase of clenbuterol is effective again.
Allergy / Mast-Cell (Medical)
Its actual approved use: allergic conditions and asthma prophylaxis, plus a sleep-aid side benefit some users appreciate given its sedation.
Benefits
- Upregulates beta-2 receptors, extending clenbuterol's effective window
- Counteracts the tolerance that normally limits beta-2 agonists to ~2 weeks
- Can 'reset' downregulated receptors, restoring clenbuterol response
- Sedating: a useful side benefit for sleep during a stimulant-heavy cut
- Inexpensive, non-hormonal
Good to Know
It resurrects clenbuterol by upregulating beta-2
Clenbuterol stops working after ~2 weeks because beta-2 receptors downregulate. Ketotifen (an antihistamine) upregulates those receptors, so it is used to extend or reset a clen run rather than cycling off.
It is sedating, dose at night
Ketotifen causes drowsiness, so it is taken before bed. That timing also conveniently offsets clenbuterol's stimulant insomnia.
Short course, not indefinite
It is used in short blocks (a couple of weeks) alongside clen, not run forever, and it is not a fat-burner itself, purely a potentiator.
Dosage Guidelines
| Experience Level | Dosage Range |
|---|---|
| Beginner | 1 – 1 mg/day |
| Intermediate | 1 – 2 mg/day |
| Advanced | 2 – 3 mg/day |
Usual PED dose is 1-2mg (up to ~3mg) taken at night because of sedation. Two common approaches: run it through the last ~2 weeks of a clenbuterol cycle to keep receptors up, or use it during a clen break to reset receptors before the next phase. Do not run it continuously for more than ~3 weeks at a time (sedation and diminishing returns); take a break before repeating. Start at 1mg to gauge how sedating it is for you.
Biphasic elimination: a short ~3-5 hour distribution phase followed by a ~21 hour terminal phase, long enough for once- or twice-daily dosing.
Side Effects
Sedation / Drowsiness
very commonThe main side effect: it crosses the blood-brain barrier and makes most users drowsy, sometimes with grogginess the next morning.
Take at night; start at 1mg and titrate; avoid driving until you know your response.
Increased Appetite / Weight Gain
commonLike many antihistamines, it can stimulate appetite, mildly counterproductive when the whole point of the clen cycle is fat loss.
Stay disciplined with intake; keep the ketotifen phase short.
Dry Mouth / Dizziness
uncommonAnticholinergic-type dryness and mild dizziness.
Hydrate; usually mild and transient.
Thrombocytopenia (rare)
rareRare reversible drops in platelet count reported, mainly when combined with certain oral antidiabetics.
Not a routine concern at short-course doses; relevant mainly with specific drug combinations.
General Mitigation Strategies
The practical issues are sedation and appetite. Dose at night, start low, and keep the course short (2-3 weeks). Be mindful the appetite bump works against a cut. It is a receptor tool, not a fat burner. Note the broader point: ketotifen itself is benign, but the thing it enables (clenbuterol) carries the real cardiovascular risk, so most of the safety attention belongs on the clen, not the ketotifen.
Post Cycle Therapy (PCT)
Not hormonal. No PCT required.
How It Works
Beyond blocking H1 histamine receptors and stabilising mast cells, ketotifen increases beta-2 adrenergic receptor density on cell membranes. Clenbuterol works by stimulating beta-2 receptors to drive lipolysis and thermogenesis, but chronic stimulation causes those receptors to downregulate (fall in number), so within roughly 2-3 weeks clenbuterol's effect fades. Ketotifen counteracts that downregulation: a 1990 study (Huszar et al.) found combining ketotifen with clenbuterol significantly improved beta-adrenergic receptor function versus clenbuterol alone, effectively 'resetting' the receptors so the beta-2 agonist keeps working. Being a first-/second-generation antihistamine that crosses the blood-brain barrier, it is also sedating.
Fundamentals
Reference on the practices relevant to Ketotifen: how they are done and where they go wrong. Not a recommendation to use it.
Legal Status
Oral ketotifen has no FDA-approved product in the USA. It is obtained via compounding pharmacies with a prescription. It is a prescription-only oral tablet in Canada, the UK, and most other countries. The ophthalmic (eye drop) form is available over the counter in the USA.
Legal status varies by country and changes over time. This is a general summary, not legal advice.
WADA Status
Ketotifen is an antihistamine and is not itself on the WADA Prohibited List. Note, however, that clenbuterol, the drug it is used to potentiate, IS prohibited (S1.2, Other Anabolic Agents, a non-specified substance), banned at all times (in and out of competition).